| 4 | FMR LLC | 24.5M | $1.37B | -2.5% | 5.530% | 0.06% |
| 5 | STATE STREET CORP | 12.3M | $691.8M | +12.3% | 2.783% | 0.01% |
| 6 | Swedbank AB | 10.7M | $601.4M | -7.4% | 2.420% | 0.52% |
| 7 | BAILLIE GIFFORD & CO | 10.0M | $561.6M | -38.0% | 2.260% | 0.51% |
| 8 | Capital World Investors | 9.5M | $533.6M | +18.4% | 2.147% | 0.06% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 8.1M | $450.6M | +2.4% | 1.818% | 0.02% |
| 10 | Caledonia (Private) Investments Pty Ltd | 5.8M | $323.9M | -19.4% | 1.303% | 11.06% |
| 11 | NORGES BANK | 5.3M | $299.2M | — | 1.204% | 0.03% |
| 12 | VANGUARD CAPITAL MANAGEMENT LLC | 4.8M | $270.6M | +6.5% | 1.089% | 0.01% |
| 13 | NORTHERN TRUST CORP | 4.7M | $264.6M | +23.9% | 1.065% | 0.03% |
| 14 | ROYAL LONDON ASSET MANAGEMENT LTD | 4.3M | $242.2M | +13.4% | 0.975% | 0.45% |
| 15 | AQR CAPITAL MANAGEMENT LLC | 4.3M | $241.4M | +13.8% | 0.971% | 0.08% |
| 16 | Invesco Ltd. | 4.2M | $237.3M | +12.8% | 0.955% | 0.02% |
| 17 | BANK OF AMERICA CORP /DE/ | 4.1M | $232.7M | +18.7% | 0.936% | 0.01% |
| 18 | Legal & General Group Plc | 3.8M | $213.1M | +13.0% | 0.857% | 0.04% |
| 19 | Amundi | 3.7M | $208.8M | +20.6% | 0.840% | 0.05% |
| 20 | VICTORY CAPITAL MANAGEMENT INC | 3.7M | $206.5M | -4.4% | 0.831% | 0.12% |
| 21 | Patient Capital Management, LLC | 3.6M | $201.8M | -1.2% | 0.812% | 6.61% |
| 22 | UBS Group AG | 3.1M | $176.2M | +73.5% | 0.709% | 0.02% |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3.1M | $172.9M | +1.8% | 0.696% | 0.02% |
| 24 | TWO SIGMA INVESTMENTS, LP | 2.9M | $163.7M | +29.7% | 0.659% | 0.12% |
| 25 | DEUTSCHE BANK AG\ | 2.7M | $152.4M | +10.8% | 0.613% | 0.04% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in RPRX — a direct measure of their conviction.
| 68.45% |
| +1.75 pp |
| $9.62B |
| +22% |
| Q4 2024 | 404 | +5.5% | 66.70% | +1.51 pp | $7.86B | 8.3% |
| Q3 2024 | 383 | — | 65.19% | — | $8.58B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
RPRX institutional ownership rose by 3.25 percentage points quarter-over-quarter, with a net change of +65 holders.
The top 10 institutions account for 53.3% of all reported 13F value in RPRX, and the top 25 account for 70.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Royalty Pharma plc (RPRX) Institutional Ownership